Clinical Trials
97 trialsHigh Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
M.D. Anderson Cancer Center
INDIGO
Boston Scientific Corporation
Organoid Models of Hepatocellular Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
Peking University First Hospital
ELEGANCE
Nantes University Hospital
The Vanguard Study: Testing a New Way to Screen for Cancer
National Cancer Institute (NCI)
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Shanghai Zhongshan Hospital
MWA Sim
NE Scientific INC
PREMIUM
VA Office of Research and Development
LASER
Seoul National University Hospital
Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic Malignancies
Seoul National University Hospital
Electronic Symptom Monitoring of Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial
Peking University
EUS-SPV
Chinese University of Hong Kong
PDO
Chinese University of Hong Kong
Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery
Cairo University
PREDICT-HCC
Centre Hospitalier Universitaire de Besancon
BISHOP
University of Aarhus
FASTRAK
Assistance Publique - Hôpitaux de Paris
CHOC
University Hospital, Angers
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
Asan Medical Center
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
University of California, Irvine
HALT
National Cancer Centre, Singapore
Phase II Trial of Immunonutrition in Hepatectomy
Tata Memorial Centre
REMNANT
University Hospital, Rouen
ELMIRA
Nantes University Hospital
Needle-based Percutaneous Ablation of Liver Tumors.
inTumo Therapeutics, Inc.
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
The University of Hong Kong
Intravital Microscopy in Human Solid Tumors
Mayo Clinic
Adjuvant PD-1 Inhibitor for Patients With Early-stage Hepatocellular Carcinoma Following Microwave Ablation
Tongji Hospital
A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE)
Yonsei University
Study on the Therapeutic Effect of Different Infusion Times of Tislelizumab on Postoperative High-risk Hepatocellular Carcinoma
Sir Run Run Shaw Hospital
HIMIKO
Nantes University Hospital
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
University of California, San Francisco
REVISE-HCC
Manchester University NHS Foundation Trust
Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
Taichung Tzu Chi Hospital
HARMONY
Massachusetts General Hospital
A Two-Arm, Multicenter, Non-Randomized Controlled Study on the Efficacy of Yttrium-90 (Selective Internal Radiation Therapy) Therapy and Hepatic Arterial Infusion Chemotherapy (Hepatic Artery Infusion Chemotherapy) for Potentially Resectable Intermediate and Advanced Hepatocellular Carcinoma
First Affiliated Hospital of Jinan University
TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
Sun Yat-sen University
CTMH
Northern Jiangsu People's Hospital
TRE+HE
University of California, San Diego
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
University of Texas Southwestern Medical Center
REALM
Ochsner Health System
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Englewood Hospital and Medical Center
HepQuant
Montefiore Medical Center
Targeted Navigation in Hepatocellular Carcinoma (HCC)
University of Miami
LILIPSY
University Hospital, Montpellier
HEPGEN
University Hospital, Montpellier
ICT-HCC
Nanjing Tianyinshan Hospital
ctDNA Monitoring in Patients With HCC and mCRC
Medical University of Warsaw
The Dragon PLC Trial (DRAGON-PLC)
Maastricht University